Clinical Trials Logo

Multiple Pulmonary Nodules clinical trials

View clinical trials related to Multiple Pulmonary Nodules.

Filter by:

NCT ID: NCT05963945 Completed - Pleural Effusion Clinical Trials

Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice

Start date: October 18, 2022
Phase:
Study type: Observational

The primary objective is to evaluate the performance parameters of the proposed DLAD (Carebot AI CXR) in comparison to individual radiologists.

NCT ID: NCT05867953 Recruiting - Lung Cancer Clinical Trials

Assessment of Tool Placement in Pulmonary Nodule(s) Using a Robotic Navigational Bronchoscopy System

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The aim of this research study is to evaluate the effectiveness of the ION endoluminal system at reaching and obtaining biopsies from lung nodules when used in combination with 3-dimensional imaging such as CT scans. Data on safety will also be collected.

NCT ID: NCT05848635 Not yet recruiting - Ablation Clinical Trials

Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled

Start date: May 1, 2023
Phase: Phase 4
Study type: Interventional

This randomized, parallel controlled, single blind trial is designed to evaluate the efficacy and safety of hydromorphone versus morphine for perioperative analgesia in lung tumor ablation.

NCT ID: NCT05817110 Recruiting - Lung Malignancy Clinical Trials

Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.

CREATE
Start date: April 20, 2023
Phase:
Study type: Observational

Artificial intelligence (AI) based algorithms have demonstrated increased accuracy in predicting the risk of Lung Cancer among patients with an incidental pulmonary nodule (IPN) on chest radiographs. Qure.ai, an AI company specializing in the reading of chest X- Rays (CXRs) by a proprietary algorithm and has developed a new model, qXR, that can report the lung nodule malignancy score (LNMS) based on lung nodule features. Our study aims to prospectively validate the lung nodule malignancy score against radiologist assessment of CT scans and Lung CT Screening Reporting and Data System score (Lung-RADS).(lung RADS score explained below) Thus, lung nodule malignancy score (interpreted by qXR as a high or low category) will be compared with radiologist-based assessment probability of CT scan and Lung-RADS assessment. The results of this prospective observational study will pave the way for improved nodule management, leading to better clinical outcomes in patients with incidental pulmonary nodule (IPNs), especially concerning malignancy assessment.

NCT ID: NCT05804435 Withdrawn - Clinical trials for Solitary Pulmonary Nodule

iNod™ Ultrasound-Guided Needle Biopsy System Study

Start date: January 2025
Phase: N/A
Study type: Interventional

The purpose of this study is to collect information on the iNod™ System's safety and ability to see the iNod™ biopsy needle in real-time in endobronchial lesions, peripheral lung nodules, or lung masses.

NCT ID: NCT05738031 Withdrawn - Lung; Node Clinical Trials

Investigating Incidental Pulmonary Nodules in Underserved Communities

Start date: October 2023
Phase:
Study type: Observational

The study team hypothesizes that incidentally discovered pulmonary nodules are often under captured and/or not surveilled in accordance with published guidelines in the Montefiore Health System, which cares for a large proportion of Black and Hispanic patients. Incidental Pulmonary Nodules (IPNs) require a pragmatic approach to follow-up and management, especially in racially disparate populations who have greater potential for lung cancer morbidity and mortality.

NCT ID: NCT05562895 Recruiting - Lung Cancer Clinical Trials

A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy

Start date: December 31, 2022
Phase:
Study type: Observational

The overall objective of this study is to evaluate procedure characteristics of pulmonary nodule biopsies using the integrated version of Cios Spin and the Ion Endoluminal System.

NCT ID: NCT05525260 Recruiting - Pulmonary Nodules Clinical Trials

Limonene for Pulmonary Nodule Chemoprevention

Start date: February 2023
Phase: Phase 2
Study type: Interventional

The prevention and treatment of lung nodules involves many fields in preventive medicine and clinical medicine. A nodule is a growth or lump that may be malignant (cancer) or benign (not cancer). This study is aim to investigate the chemopreventive effect of limonene in inhibiting the occurrence/progression of ground glass pulmonary nodules. It is expected that limonene can be used as a safe and effective chemopreventive agent for preventing the development/progress of pulmonary nodules as well as expanding the indications of limonene.

NCT ID: NCT05518669 Recruiting - Lung Cancer Clinical Trials

mCBCT in Combination With ENB for the Diagnosis of PPNs

Start date: September 26, 2022
Phase:
Study type: Observational

This study aims to evaluate the clinical value of mobile cone-beam CT (mCBCT) in combination with electromagnetic navigation bronchoscopy for the diagnosis of peripheral pulmonary nodules, and to explore the value of mCBCT in improving the diagnostic yield by calculating the improvement in diagnostic yield of patients before and after mCBCT adjustments.

NCT ID: NCT05512533 Recruiting - Clinical trials for Peripheral Pulmonary Nodules

Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs

Start date: August 22, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the diagnostic value and safety of Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS) Scope for peripheral pulmonary lesions (PPLs)